Among them, the NF1 mutation was indicated by NGS and confirmed using Sanger sequencing (Figure 4A) in one tumor (case #3) showing weak-moderate expression of Pan-TRK (Figure 4B), and this patient was diagnosed with NF1 syndrome based on the clinical characteristics. This evidence concerns the gene NF1 and neoplasm.